<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04800445</url>
  </required_header>
  <id_info>
    <org_study_id>MS-53-2020</org_study_id>
    <nct_id>NCT04800445</nct_id>
  </id_info>
  <brief_title>Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis</brief_title>
  <official_title>Salivary C-reactive Protein,Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil&#xD;
      -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 4, 2020</start_date>
  <completion_date type="Anticipated">January 10, 2022</completion_date>
  <primary_completion_date type="Actual">December 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary c reactive protein in neonatal sepsis</measure>
    <time_frame>28 days</time_frame>
    <description>Salivary C reactive protein of value as non invasive procedure in diagnosis of neonatal sepsis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean platelet volume</measure>
    <time_frame>28 days</time_frame>
    <description>Asses the validity of Mean Platlet Volume as marker of neonatal sepsis which is equal about ( 9 - 11.4 ) in septic group and about ( 7.5 - 8.5 ) in control group</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>Case group of fullterm neonates with neonatal sepsis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy fullterm neonates</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Salivary CRP</intervention_name>
    <description>Salivary C reactive protein in neonatal sepsis</description>
    <arm_group_label>Case group of fullterm neonates with neonatal sepsis</arm_group_label>
    <arm_group_label>Healthy fullterm neonates</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Full term neonates of both genders from birth to the 28th day of life who were admitted to&#xD;
        Cairo University NICU with clinical features of either early- or late-onset neonatal sepsis&#xD;
        diagnosed by culture, CRP more than 10 ,and has three or more the clinical findings of&#xD;
        sepsis were enrolled in this study.&#xD;
&#xD;
        Neonates with no symptoms or signs suggestive 0f sepsis who had been hospitalized In Cairo&#xD;
        University Nicu . Serum CRP level for neonates in this group was negative (CRP &lt; 10 mg/L)&#xD;
        as control group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - Full term neonates of both genders from birth to the 28th day of life diagnosed with&#xD;
             sepsis by history, clinical findings, laboratory findings, and blood culture. The&#xD;
             clinical findings included the presence of three or more of the following:&#xD;
&#xD;
          -  (1) temperature instability (hypothermia, hyperthermia) .&#xD;
&#xD;
          -  (2) respiratory alterations (grunting, intercostal retractions, apnea, tachypnea,&#xD;
             cyanosis) .&#xD;
&#xD;
          -  (3) cardiovascular alterations (bradycardia, tachycardia, poor perfusion, hypotension)&#xD;
             .&#xD;
&#xD;
          -  (4) neurologic alterations (hypotonia, lethargy, seizures)&#xD;
&#xD;
          -  (5) gastrointestinal alterations (feeding intolerance, abdominal distension). CRP&#xD;
             values &gt;10 mg/L were considered to be positive.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Preterm neonates .&#xD;
&#xD;
          -  Neonates with CNS malformations, metabolic disorders, chromosomal abnormalities,&#xD;
             intrauterine growth restriction, or birth asphyxia were excluded from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of medicine</name>
      <address>
        <city>Cairo</city>
        <state>Almanyal</state>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Eslam Mohamed Naeim</investigator_full_name>
    <investigator_title>Emergency medicine and traumatology resident in sharq el madina hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

